Cargando…
Modern surgical management of incidental gliomas
PURPOSE: Gliomas are the most common primary tumors of the central nervous system and are categorized by the World Health Organization into either low-grade (grades 1 and 2) or high-grade (grades 3 and 4) gliomas. A subset of patients with glioma may experience no tumor-related symptoms and be incid...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325816/ https://www.ncbi.nlm.nih.gov/pubmed/35704158 http://dx.doi.org/10.1007/s11060-022-04045-0 |
_version_ | 1784757140557135872 |
---|---|
author | Pradhan, Anjali Mozaffari, Khashayar Ghodrati, Farinaz Everson, Richard G. Yang, Isaac |
author_facet | Pradhan, Anjali Mozaffari, Khashayar Ghodrati, Farinaz Everson, Richard G. Yang, Isaac |
author_sort | Pradhan, Anjali |
collection | PubMed |
description | PURPOSE: Gliomas are the most common primary tumors of the central nervous system and are categorized by the World Health Organization into either low-grade (grades 1 and 2) or high-grade (grades 3 and 4) gliomas. A subset of patients with glioma may experience no tumor-related symptoms and be incidentally diagnosed. These incidental low-grade gliomas (iLGG) maintain controversial treatment course despite scientific advancements. Here we highlight the recent advancements in classification, neuroimaging, and surgical management of these tumors. METHODS: A review of the literature was performed. The authors created five subtopics of focus: histological criteria, diagnostic imaging, surgical advancements, correlation of surgical resection and survival outcomes, and clinical implications. CONCLUSIONS: Alternating studies suggest that these tumors may experience higher mutational rates than their counterparts. Significant progress in management of gliomas, regardless of the grade, has been made through modern neurosurgical treatment modalities, diagnostic neuroimaging, and a better understanding of the genetic composition of these tumors. An optimal treatment approach for patients with newly diagnosed iLGG remains ill-defined despite multiple studies arguing in favor of safe maximal resection. Our review emphasizes the not so benign nature of incidental low grade glioma and further supports the need for future studies to evaluate survival outcomes following surgical resection. |
format | Online Article Text |
id | pubmed-9325816 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-93258162022-07-28 Modern surgical management of incidental gliomas Pradhan, Anjali Mozaffari, Khashayar Ghodrati, Farinaz Everson, Richard G. Yang, Isaac J Neurooncol Topic Review PURPOSE: Gliomas are the most common primary tumors of the central nervous system and are categorized by the World Health Organization into either low-grade (grades 1 and 2) or high-grade (grades 3 and 4) gliomas. A subset of patients with glioma may experience no tumor-related symptoms and be incidentally diagnosed. These incidental low-grade gliomas (iLGG) maintain controversial treatment course despite scientific advancements. Here we highlight the recent advancements in classification, neuroimaging, and surgical management of these tumors. METHODS: A review of the literature was performed. The authors created five subtopics of focus: histological criteria, diagnostic imaging, surgical advancements, correlation of surgical resection and survival outcomes, and clinical implications. CONCLUSIONS: Alternating studies suggest that these tumors may experience higher mutational rates than their counterparts. Significant progress in management of gliomas, regardless of the grade, has been made through modern neurosurgical treatment modalities, diagnostic neuroimaging, and a better understanding of the genetic composition of these tumors. An optimal treatment approach for patients with newly diagnosed iLGG remains ill-defined despite multiple studies arguing in favor of safe maximal resection. Our review emphasizes the not so benign nature of incidental low grade glioma and further supports the need for future studies to evaluate survival outcomes following surgical resection. Springer US 2022-06-15 2022 /pmc/articles/PMC9325816/ /pubmed/35704158 http://dx.doi.org/10.1007/s11060-022-04045-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Topic Review Pradhan, Anjali Mozaffari, Khashayar Ghodrati, Farinaz Everson, Richard G. Yang, Isaac Modern surgical management of incidental gliomas |
title | Modern surgical management of incidental gliomas |
title_full | Modern surgical management of incidental gliomas |
title_fullStr | Modern surgical management of incidental gliomas |
title_full_unstemmed | Modern surgical management of incidental gliomas |
title_short | Modern surgical management of incidental gliomas |
title_sort | modern surgical management of incidental gliomas |
topic | Topic Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325816/ https://www.ncbi.nlm.nih.gov/pubmed/35704158 http://dx.doi.org/10.1007/s11060-022-04045-0 |
work_keys_str_mv | AT pradhananjali modernsurgicalmanagementofincidentalgliomas AT mozaffarikhashayar modernsurgicalmanagementofincidentalgliomas AT ghodratifarinaz modernsurgicalmanagementofincidentalgliomas AT eversonrichardg modernsurgicalmanagementofincidentalgliomas AT yangisaac modernsurgicalmanagementofincidentalgliomas |